PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 43 filers reported holding PROQR THRAPEUTICS N V in Q3 2020. The put-call ratio across all filers is 6.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $118,999 | +71.6% | 55,868 | +198.0% | 0.00% | – |
| Q4 2022 | $69,364 | +433.6% | 18,747 | +4.0% | 0.00% | – |
| Q3 2022 | $13,000 | -88.7% | 18,025 | -87.8% | 0.00% | – |
| Q2 2022 | $115,000 | +447.6% | 147,558 | +550.4% | 0.00% | – |
| Q1 2022 | $21,000 | -84.8% | 22,689 | +32.1% | 0.00% | – |
| Q4 2021 | $138,000 | +43.8% | 17,174 | +49.6% | 0.00% | – |
| Q3 2021 | $96,000 | -90.2% | 11,482 | -92.3% | 0.00% | – |
| Q1 2021 | $982,000 | +1593.1% | 148,693 | +975.1% | 0.00% | – |
| Q4 2020 | $58,000 | 0.0% | 13,831 | +15.1% | 0.00% | – |
| Q3 2020 | $58,000 | -37.0% | 12,012 | +18.5% | 0.00% | – |
| Q2 2019 | $92,000 | – | 10,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |